MEHTA API Pvt. Ltd.
Overview
Pharmaceutical manufacturing site surfaced via EU GMP non-compliance screening (EudraGMDP).
API / Drug Master Files
MEHTA API Pvt. Ltd. holds 8 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- VISMODEGIB IHActive2026-03-16
- AGOMELATINE IHActive2026-02-03
- CINACALCET HYDROCHLORIDE IHActive2025-12-08
- DROPERIDOL USPActive2025-07-02
- LANDIOLOL HYDROCHLORIDEActive2025-01-29
- MIRABEGRON EPActive2024-10-18
- CARIPRAZINE HYDROCHLORIDE IHActive2024-09-12
- ESMOLOL HCL USPActive2024-01-31
FDA compliance signals
1 FDA enforcement record linked to this company.
- eu_noncompliance2019-11-25
EU GMP Statement of Non-Compliance
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.